Disc Medicine

About:

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Website: https://www.discmedicine.com

Twitter/X: discmedicine

Top Investors: Hercules Capital, OrbiMed, Alexandria Venture Investments, Wellington Management, Novo Holdings

Description:

Disc Medicine is a clinical-stage biopharmaceutical company focused on discovering, and developing innovative treatments for patients with severe hematologic disorders. The company's pipeline includes bitopertin for the treatment of erythropoietic porphyrias and diamond-blackfan anemia.

Total Funding Amount:

$793M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Watertown, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)discmedicine.com

Founders:

Brian MacDonald

Number of Employees:

51-100

Last Funding Date:

2024-11-08

IPO Status:

Public

© 2025 bioDAO.ai